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Amyloid formation involves the conversion of soluble protein
species to an aggregated state. Amyloid fibrils of β-parvalbumin, a
protein abundant in fish, act as an allergen but also inhibit the
in vitro assembly of the Parkinson protein α-synuclein. However,
the intrinsic aggregation mechanism of β-parvalbumin has not yet
been elucidated. We performed biophysical experiments in combi-
nation with mathematical modeling of aggregation kinetics and
discovered that the aggregation of β-parvalbumin is initiated by
the formation of dimers stabilized by disulfide bonds and then
proceeds via primary nucleation and fibril elongation processes.
Dimer formation is accelerated by H2O2 and hindered by reducing
agents, resulting in faster and slower aggregation rates, respec-
tively. Purified β-parvalbumin dimers readily assemble into amy-
loid fibrils with similar morphology as those formed when starting
from monomer solutions. Furthermore, addition of preformed di-
mers accelerates the aggregation reaction of monomers. Aggrega-
tion of purified β-parvalbumin dimers follows the same kinetic
mechanism as that of monomers, implying that the rate-limiting
primary nucleus is larger than a dimer and/or involves structural
conversion. Our findings demonstrate a folded protein system in
which spontaneously formed intermolecular disulfide bonds ini-
tiate amyloid fibril formation by recruitment of monomers. This
dimer-induced aggregation mechanism may be of relevance for
human amyloid diseases in which oxidative stress is often an
associated hallmark.
amyloid fibrils | dimer formation | disulfide bond | dimer-induced
aggregation | kinetic analysis
Amyloid fibrils are highly ordered protein assemblies char-acterized by β-strands arranged perpendicularly to the fibril
axis forming cross-β sheets of indefinite length (1). They are
generally associated with human disorders, such as Alzheimer’s
disease, Parkinson’s disease and type 2 diabetes (2–4); however, it
is clear that organisms also exploit the cross-β sheet structure for
function. For example, amyloid fibrils are part of the human
melanosome ultrastructure (5) and are common structural com-
ponents of bacterial biofilms (6). Amyloid fibrils can form either
from intrinsically disordered proteins, such as α-synuclein, which is
linked to Parkinson’s disease, or by folded globular proteins, such
as β2-microglobulin. Amyloid formation proceeds via at least two
reaction steps: primary nucleation and elongation of fibrils (1, 7).
The process is also typically catalyzed by secondary processes in-
cluding secondary nucleation (1, 7) and, in some cases, fibril
fragmentation (8). There are also cases of amyloid formation
without rate-limiting nucleation; for example, on dissociation of
tetrameric transthyretin to monomers, amyloid formation follows
a downhill polymerization mechanism (9).
Disulfide bonds, which stabilize the folded structure of pro-
teins, are present in several amyloidogenic proteins, but their
role in amyloid formation is complex and remains a subject of
some controversy (10–14). It has been demonstrated that the
reduction of the single disulfide bond of the C-terminal domain
of the human prion protein (PrP) accelerates amyloid formation
in denaturing solution at neutral pH compared with the oxidized
form (15). In contrast, at acidic pH and denaturing conditions,
only the oxidized form of the C-terminal of PrP aggregates into
amyloid fibrils (10). The reduction of the conserved disulfide
bond in islet amyloid polypeptide, whose aggregation is a path-
ological hallmark of type 2 diabetes, accelerates amyloid for-
mation in solution and in the presence of membranes, but
cytotoxicity is not affected (16). Studies on β2-microglobulin have
shown that at neutral pH, reduction of its single disulfide bond
leads to aggregation but not amyloid formation (12, 13, 17). At
acidic pH, however, reduced β2-microglobulin can either form
(at high salt concentrations) or not form (in the presence of
seeds) amyloid fibrils depending on the solution conditions (12,
13). In the case of lysozyme, the presence of intact disulfide
bonds in the protein was observed to decrease the rate of amy-
loid fibril formation (11), but in another study, those bonds were
found to be required for amyloid formation (18). It has been
proposed that the disulfide bonds in lysozyme inhibit amyloid
formation by stabilizing the folded state, but under structure-
destabilizing conditions, a partially unfolded state can be popu-
lated, in which case they are essential for fibril formation (11).
Moreover, in the case of insulin with several intramolecular
disulfide bonds, these bonds have been shown to be important
for aggregation (19).
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Our understanding is more limited when considering inter-
molecular disulfide bonds in amyloid formation. Interprotein
disulfide bonds have been found in amyloid fibrils of Cu/Zn
superoxide dismutase, whose mutations are linked to familial
amyotrophic lateral sclerosis, but interprotein disulfides are not
required for fibril formation (20). In addition, a transthyretin
mutant, the Tyr114Cys variant, which is implicated in familial
amyloidotic polyneuropathy, was found to form intermolecular
disulfide bonds that partly impaired amyloid fibril formation (21).
However, the Cys10Ala/Tyr114Cys transthyretin variant formed
dimers via disulfide bridges that then proceeded to amyloid pro-
tofibrils (22). In the case of the human tumor suppressor
p16INK4A, with one cysteine residue, the addition of oxidants was
found to induce the formation of disulfide-bridged dimers, which
then aggregate into amyloid fibrils (23).
Here we investigated the role of intermolecular disulfide bonds
in amyloid fibril formation of Gadus morhua β-parvalbumin
(β-PV). β-PV is an α-helical protein with a single conserved cys-
teine residue (Cys19) (24) that was recently suggested to be nec-
essary for amyloid fibril formation (25). β-PV is abundantly
expressed in fish muscles (26) and has three EF-hand (helix-loop-
helix motif) domains, of which two bind metals (Mg2+ and/or
Ca2+), acting as a Ca2+ buffer in muscle cells (27). It has been
reported that β-PV forms amyloid fibrils in vitro as a result of
Ca2+ removal, which can be induced by protonation of Ca2+
binding residues at low pH or by using chelating agents such as
EDTA (28). Antibodies against β-PV epitopes can be detected in
the blood after eating fish (29), and studies have shown that an-
tibodies from fish-allergic people bind 1,000-fold more strongly to
β-PV in its amyloid conformation than to the monomeric protein
(28, 30). Thus, it is speculated that β-PV forms amyloid fibrils in
the gut due to the low pH inducing metal ion dissociation. The
amyloid structure then protects β-PV against gastrointestinal
degradation (28). We have recently reported that β-PV amyloid
fibrils may, in addition to their allergenic properties, have bene-
ficial effects as they are capable of inhibiting aggregation of the
Parkinson protein α-synuclein in vitro through sequestration of
α-synuclein polypeptides to the β-PV amyloid fibril surface (31). In
this study, we provide evidence that β-PV, in its apo state, spon-
taneously forms disulfide-bridged dimers that stimulate the for-
mation of primary nuclei, which are then capable of templating
monomer as well as dimer additions to the ends of growing
amyloid fibrils.
Results
Kinetic Analysis of Apo β-PV Amyloid Formation. The aggregation of
β-PV in the presence of EDTA was monitored at 37 °C using the
thioflavin T (ThT) fluorescence assay (32, 33). The presence of
only protein monomers at the starting point was ensured by
performing size-exclusion chromatography (SEC) of the samples
before each aggregation experiment. The EDTA was added at
the start of the reaction as apo β-PV begins to aggregate im-
mediately. By monitoring the amyloid formation of apo β-PV in a
wide concentration range (26 to 100 μM), we found that the
aggregation rate increases in a concentration-dependent manner
(Fig. 1A). Notably, the aggregation curves are rather atypical for
amyloid formation as they exhibit short lag phases. We plotted
the ThT fluorescence half-time (i.e., the time at which 50% final
fluorescence has been achieved) against the protein concentra-
tion in a double-logarithmic plot to investigate the concentration
dependence of apo β-PV aggregation (Fig. 1B). A linear de-
pendence was found with a slope (corresponding to the so-called
scaling parameter, γ) of −1.1 ± 0.1 (Fig. 1B and SI Appendix,
Table S1). The scaling parameter acts as a rough guide to the
involved mechanism (7) and can be related to the reaction order
of the nucleation process, n. For a reaction dominated by pri-
mary processes, γ corresponds to −nc/2 and a γ value of −1 and
means that nc = 2; if secondary processes are also involved, then
γ corresponds to −(n2 + 1)/2, and then a γ value of −1 means
that n2 = 1 (7). Regardless of the mechanism, the fact that the
log-log dependence of the half-time on the protein concentration
is linear suggests that a single aggregation mechanism dominates
across the entire protein concentration range (7).
We globally fitted mathematical models of amyloid formation
to the kinetic data of apo β-PV aggregation at the different con-
centrations using the web-based AmyloFit program (7). The
analysis revealed that a mechanistic model involving only primary
nucleation and elongation steps fitted the data best (Fig. 1A). The
convoluted rate constant factor knk+ (7), describing the combined
rate of primary nucleation (kn) and elongation (k+), for the global
fit shown in Fig. 1A was found to be 2.7 × 106 ± 1.1 × 106 M−2h−2
(SI Appendix, Table S1). Reasonable global fits to the data were
also obtained if secondary nucleation was added to the model,
besides primary nucleation and elongation (SI Appendix, Fig.
S1A), but including a fragmentation step resulted in worse fits (SI
Appendix, Fig. S1B).
To assess for the presence of secondary nucleation processes, we
performed seeded aggregation experiments in which we added
preformed full-length apo β-PV fibrils, up to 5% monomer equiv-
alents, to protein monomers. In an amyloid formation reaction with
strong influence from secondary nucleation processes, the addition
of small amounts of preformed fibrils (not sonicated) should dras-
tically increase the aggregation rate (34). From our results, however,
it is evident that the addition of preformed apo β-PV fibrils (up to
5%) has no effect on apo β-PV amyloid formation kinetics
(Fig. 1C). Thus, in accordance with the mathematical modeling, it
appears that primary processes (nucleation-elongation) dominate
apo β-PV aggregation. However, for reactions with only primary
processes, there should also be some acceleration of aggregation on
the addition of amyloid seeds, as the presence of sufficient amount
of free fibril ends should allow for rapid elongation without nu-
cleation. Therefore, we performed seeding experiments with higher
concentrations of amyloid fibril seeds (that had also been sonicated
to create more fibril ends). Under these conditions, we observed
clear seeding effects such that the lag phase was abolished (SI
Appendix, Fig. S2A).
As described previously, Ca2+-bound β-PV (holo β-PV) does
not form amyloid fibrils (28, 31). To test whether holo β-PV
could be forced to form amyloid via seeding, we added pre-
formed apo β-PV fibrils to holo β-PV, but found that they did not
trigger amyloid formation of holo β-PV (Fig. 1C). In addition, as
β-PV can bind both Ca2+ and Mg2+, we also tested whether
Mg2+-bound β-PV would aggregate into amyloid fibrils, but the
data showed that the Mg2+-bound protein also does not aggre-
gate (SI Appendix, Fig. S3). Thus, only the apo-state of the
protein forms amyloid fibrils. Surprisingly, when the apo β-PV
amyloid fibrils were analyzed by nonreducing SDS/PAGE, we
detected ∼40% covalent apo β-PV dimers (Fig. 1D).
Oxidizing and Reducing Conditions Influence Apo β-PV Amyloid
Formation. The dimers detected in samples of apo β-PV amy-
loid fibrils likely result from disulfide-bond formation involving
β-PV’s cysteine, Cys19. Therefore, the influence of redox agents
on the aggregation kinetics of apo β-PV was studied by adding
H2O2 (Fig. 2A) or DTT (Fig. 2B). We found that oxidizing
conditions strongly accelerate apo β-PV amyloid formation in a
H2O2-concentration dependent manner, whereas reducing con-
ditions (using DTT) delay apo β-PV amyloid formation. Densi-
tometric analysis of SDS/PAGE data for amyloid samples show
that the fraction of dimers increased from 40% under normal
conditions to 77% of total protein in the amyloid fibrils under
oxidizing conditions, whereas dimers corresponded to only 1% of
total amyloid protein under reducing conditions (Fig. 2C). Thus,
the β-PV dimers appear to be linked by disulfide bonds, and the
presence of disulfide-bridged dimers clearly accelerate amyloid
formation.
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To obtain pure dimers for further biophysical analysis,
monomeric apo β-PV was incubated with increasing amounts
of H2O2 at 4 °C. Increasing amounts of dimers were found in
an H2O2-concentration dependent manner according to SDS/
PAGE (Fig. 3A). Notably, H2O2 did not induce dimerization
of Ca2+- or Mg2+-bound β-PV (Fig. 3A, and SI Appendix, Fig.
S4A). Dimers were purified by SEC (using Ca2+ in the run-
ning buffer to avoid aggregation). When such purified dimers
were treated with DTT, dimers resolved to monomers
according to SDS/PAGE (Fig. 3B), indicating that the di-
merization process is reversible and that the covalent bonds
involved are disulfides.
Using far-UV circular dichroism (CD) spectroscopy, we found
that the secondary structure of purified apo β-PV dimers is
similar to that of apo β-PV monomers (Fig. 3D). In the presence
of Ca2+, the dimers adopt the same folded structure as mono-
meric holo β-PV with minima at 208 and 222 nm, typical of
predominantly α-helical protein conformations (Fig. 3C).
A B
C D
Fig. 1. (A) Aggregation kinetics of apo β-PV as a function of monomer concentration, as measured by ThT fluorescence at 37 °C under quiescent conditions
(150 mM NaCl, 1 mM CaCl2, 5 mM EDTA, and 25 mM Tris·HCl pH 7.4). Solid lines indicate fits to data based on a primary nucleation model in the AmyloFit web
interface (7) (SI Appendix, Fig. S2B, nonnormalized data). (B) Double-logarithmic plot of amyloid formation half-time vs. apo β-PV concentration extracted
from the ThT data; the fitted line has a slope (γ) of −1.1. (C) Aggregation kinetics of 50 μM apo β-PV in the presence of 5% monomer equivalent preformed
apo β-PV amyloid fibrils (PFFs) at the same conditions as in A. (D) SDS/PAGE of apo β-PV fibrils obtained after incubation of protein monomers at 50 μM for
300 h.
A B C
Fig. 2. (A and B) ThT fluorescence curves of 50 μM apo β-PV at 37 °C under quiescent conditions in 150 mM NaCl, 1 mM CaCl2, 5 mM EDTA, 25 mM Tris·HCl pH
7.4, and 0 to 100 μM H2O2 (A) or 0 to 5 mM DTT (B). (C) SDS/PAGE analysis of apo β-PV amyloid fibrils from ThT kinetic experiments with or without either 100
μM H2O2 or 100 μM DTT.








Apo β-PV Dimers Form Amyloid Fibrils and Accelerate the Aggregation of
Apo-β-PV Monomers. We next tested whether purified apo β-PV di-
mers could form amyloid fibrils in the absence of monomers by
performing ThT-detected kinetic experiments with dimers at a
concentration range between 4 and 15 μM (monomer equivalents).
As observed for apo β-PV monomers, the ThT data showed faster
aggregation reactions for higher concentrations of apo β-PV dimers
(Fig. 4A). Plotting fluorescence half-time vs. protein concentration
in a double-logarithmic plot again revealed a linear dependence,
with a slope of −1.0 ± 0.1 (Fig. 4B and SI Appendix, Table S1).
Using AmyloFit, the kinetic profiles for apo β-PV dimer aggrega-
tion were well fitted with the same nucleation-elongation model
(Fig. 4A) as used to fit the kinetics of apo β-PV monomer amyloid
formation; the addition of secondary processes to the model again
resulted in worse fits. Concerning the apo β-PV dimer aggregation
reaction, the convoluted rate constant factor knk+ was determined
to be 5.7 × 107 ± 1.7 × 107 M−2h−2 (monomer equivalents) (SI
Appendix, Table S1), which is 20-fold higher than the corresponding
value found for the monomer reaction.
We also tested whether purified apo β-PV dimers could ac-
celerate the amyloid fibril formation of apo β-PV monomers. A
concentration-dependent acceleration of apo β-PV monomer
aggregation was observed on the addition of 1 to 5% (monomer
equivalents) dimers at the start of the reaction (50 μM total
protein; Fig. 4 C and D). The addition of 5% preformed dimers
(the highest concentration tested) shortened the half-time from
21.7 ± 1.5 h to 13.6 ± 1.7 h (Fig. 4 C and D). Notably, this dimer-
catalyzed reaction is still slower than the aggregation of pure
dimers (15 μM protein in monomer-equivalent dimers display an
aggregation half-time of only approx. 5 h; Fig. 4B), implying that
fibril elongation by addition of dimers is highly efficient.
Amyloid Fibrils Formed from Apo β-PV Monomers and Dimers Are
Morphologically Similar. Apo β-PV amyloid fibrils formed from
either monomeric or dimeric starting material, as well as fibrils
obtained from dimer-accelerated monomer aggregation experi-
ments, were analyzed by atomic force microscopy (AFM) to
characterize amyloid fibril morphology. We observed that all
analyzed amyloid fibrils had similar morphology, including fiber
heights, clustering preference, and curvilinear appearance (Fig. 5 A–
C). Moreover, based on far-UV CD, the different amyloid fibrils
exhibited similar content of β-sheet secondary structure (Fig. 5D).
To address whether the disulfide bonds within the amyloid
fibrils are exposed or hidden in the core, we added DTT to
preformed amyloids made from either monomeric or dimeric
apo β-PV. After incubation with DTT, SDS/PAGE revealed no
change in the amount of apo β-PV dimer amount compared with
no DTT incubation (SI Appendix, Fig. S5A), suggesting that the
disulfide bonds are not accessible to the solvent in the amyloid
fibrils. Furthermore, the addition of DTT to preformed amyloid
fibrils did not affect their morphology according to AFM (SI
Appendix, Fig. S5B; data for amyloid fibrils formed from dimers).
Discussion
Although β-PV amyloid formation on Ca2+ removal remains
poorly understood, a recent study suggested that the conserved
cysteine residue (Cys19) is critical for amyloid fibril formation
(25). On exchanging Cys19 for a serine residue, the resulting
variant aggregated more slowly than wild-type apo β-PV and
formed rod-like aggregates instead of the protofibrillar struc-
tures that are typical for wild-type β-PV (25). Therefore, we
carried out a comprehensive study of apo β-PV aggregation at
different concentrations and assessed the effect of reducing and
oxidizing conditions, as well as the influence of seed fibrils on
amyloid formation. Our results show that aggregation of apo
β-PV into amyloid fibrils at 37 °C under nonreducing conditions
involves the formation of disulfide-bridged dimers. The process
is accelerated in the presence of oxidants and delayed by re-
ducing agents in a concentration-dependent manner. Moreover,
the addition of dimers to monomeric apo β-PV increases the
protein aggregation rate, suggesting that the dimers induce nu-
clei formation. The dimers (when isolated and purified; before
aggregation) were found to be folded and to bind Ca2+ like the
monomers. Pure dimers, in the absence of Ca2+, aggregated
faster than the monomers but formed amyloid fibrils with similar






















































Fig. 3. (A) SDS/PAGE of apo and Ca2+ β-PV at a concentration of 50 μM exposed to 0 to 100 μMH2O2 in 25 mM Tris·HCl, 5 mM EDTA (for apo), and 1 mM CaCl2,
pH 8.22 at 4 °C. (B) SDS/PAGE of apo β-PV treated with H2O2 for 20 h (after SEC separation of monomer and dimer fractions with a 25 mM Tris·HCl and 1 mM
CaCl2 running buffer) and after adding 5 mM DTT to the purified dimers. (C and D) Monomer (blue) and dimer (red) CD spectra for 15 μM monomer
equivalent β-PV in 25 mM Tris·HCl and 1 mM CaCl2, without (C; holo) or with (D; apo) 5 mM EDTA, at 21 °C and pH 7.8.
28000 | www.pnas.org/cgi/doi/10.1073/pnas.2015503117 Werner et al.
morphology and β-sheet secondary structure as those formed
from monomers.
Global data analysis of the concentration dependence of the
apo β-PV aggregation kinetic curves revealed that the data were
best fitted to a simple nucleation-elongation model. The failure
of attempts to seed β-PV aggregation with preformed full-length
fibrils (up to 5%) supports an aggregation mechanism without
secondary processes. The aggregation data for both monomer
and dimer β-PV starting material fitted to the same aggregation
mechanism, demonstrating that the dimers are not competent
nuclei. Instead, the dimers need to assemble, partially unfold, or
structurally convert in the rate-limiting nucleation step before
rapid fibril elongation occurs. Notably, the kinetic models in the
AmyloFit software do not include reaction steps preceding the
A B
C D
Fig. 4. (A) Aggregation kinetics of dimeric apo β-PV as function of concentration (monomer equivalents given), as measured by ThT fluorescence at 37 °C
under quiescent conditions (150 mM NaCl, 1 mM CaCl2, 5 mM EDTA, and 25 mM Tris·HCl pH 7.4). The solid lines represent fits to data based on a primary
nucleation model in the AmyloFit web interface (7) (SI Appendix, Fig. S2C, nonnormalized data). (B) Double-logarithmic plot of half-time vs. apo β-PV dimer
concentration from ThT aggregation data. (C) ThT fluorescence of apo β-PV aggregation in the presence of 0 to 5% (monomer equivalent) apo β-PV dimers
(50 μM total apo β-PV) under the same conditions as described in A. (D) Half-time plot of the data reported in C vs. fraction of added dimers.
A B
C D
Fig. 5. (A–C) AFM images of fibrils obtained from apo β-PV monomers (A), monomers accelerated with dimers (B), or dimers only (C) . (D) CD spectra of fibrils
obtained from dimers (red) and monomers (blue). The concentration of fibrils is unknown; the CD signal was matched to 222 nm.








formation of an elongation-competent primary nucleus; thus, we
cannot assess the role of dimers in the early steps via global
kinetic fitting.
The observed γ value of −1, indicating a linear dependence be-
tween the logarithms of protein concentration and half-times, sup-
ports a simple nucleation-elongation mechanism but is also
expected for a downhill polymerization mechanism. A downhill
polymerization mechanism was demonstrated for amyloid forma-
tion of transthyretin (9) which, like β-PV, is a folded protein.
However, several observations exclude this mechanism as a likely
scenario for apo β-PV aggregation. First, apo β-PV amyloid for-
mation exhibits a lag phase, which should not be the case for
downhill polymerization. Second, in contrast to what is expected for
downhill polymerization, the apo β-PV aggregation reaction can be
seeded by the addition of preformed disulfide-bridged dimers and
the addition of high concentrations of amyloid fibril seeds. Third,
the apo β-PV kinetics experimental data are well fitted to the
nucleation-elongation model when analyzed by the AmyloFit soft-
ware. Fig. 6 shows a proposed mechanism, based on our data, for
apo β-PV amyloid formation that involves nucleation and elonga-
tion steps, in which the first step is catalyzed by disulfide-bridged
dimers. Importantly, the involvement of disulfide-bridged dimers
accelerates amyloid formation, but it remains unclear whether these
species are compulsory intermediates.
On metal ion release, β-PV can spontaneously form intermo-
lecular disulfide bonds, resulting in apo β-PV dimers, which then
catalyze the nucleation step in amyloid fibril formation. The role
of intermolecular disulfide bonds in amyloid fibril formation has
been investigated to some degree for both natural and engineered
cysteines in proteins (17, 18, 22, 23, 35). In close similarity to the
results presented here for β-PV, the human tumor suppressor
p16INK4A was shown to form amyloid fibrils on disulfide-bridged
dimerization when exposed to excess oxidizers under agitation
(23). In contrast to the β-PV reaction, which does not require
oxidizing agents nor agitation and involves a mixture of dimers
and monomers, only dimeric p16INK4A could form fibrils. In ad-
dition, disulfide-bridged dimers of the transthyretin Cys10Ala/
Tyr114Cys mutant were found to be compatible with aggregation
toward amyloid protofibrils. However, the formation of disulfide-
bridged dimers in the case of the transthyretin Tyr114Cys variant
prevented fibril formation and instead resulted in amorphous
precipitates, indicating that the latter dimers could not adopt
amyloidogenic conformations (21).
Synthetic disulfide-linked dimers of amyloid-β (the amyloido-
genic peptide linked to Alzheimer’s disease), generated by in-
troducing a cysteine in place of serine 26, were observed to
aggregate more rapidly than wild-type and mutated monomers,
but the dimers formed toxic protofibrils that did not convert into
typical amyloid fibrils (36). Synthetic disulfide-bridged dimers of
⍺-synuclein were also engineered by introducing a cysteine at
different positions in the sequence. Depending on whether the
cysteine residue was in the C terminus or the N terminus, dimer
formation resulted in either increased or reduced aggregation
rates compared with the monomer (37), suggesting that the
orientation of monomers in the dimers is important in the am-
yloid formation process of α-synuclein.
Disulfide bonds between two cysteine sulfurs can form spon-
taneously in vitro in the presence of dissolved O2 (38, 39). Our
results show that dimer formation of β-PV readily occurs for the
apo protein, but not when the protein is loaded with Ca2+ or
Mg2+. The differential behavior of apo and holo β-PV correlates
with high-resolution structural data of the mammalian homolog
(also known as oncomodulin), showing that the cysteine is buried
in the holo form of β-PV but solvent-exposed in the apo form of
β-PV (SI Appendix, Fig. S6) (24, 40, 41). In accordance with this,
we found using Ellman’s assay that the cysteine in monomeric
apo β-PV readily reacts with Ellman’s reagent, indicating high
solvent accessibility, whereas the cysteine residue is more pro-
tected in monomeric Ca2+- and Mg2+-loaded β-PV proteins (SI
Appendix, Fig. S4B).
As β-PV cycles between Ca2+- and Mg2+-bound forms during
fish muscle contractions (27), there should never be true “apo”
β-PV, and thus no amyloid formation, under normal conditions
in vivo. Only when fish β-PV is placed in strongly destabilizing
environments, such as in the human gut, can dissociation of
metal ions result in disulfide bond formation and assembly into
amyloid fibrils. In our experiments, EDTA addition was used to
trigger the reaction by removing all metal ions from β-PV. To
link to biology, we tested whether apo β-PV amyloid fibrils
formed under gut pH conditions (i.e., low pH) contained
disulfide-bridged dimers. Although disulfide bonds are dis-
favored at low pH, we detected a fraction of dimers in amyloid
formed at pH 2.3 (SI Appendix, Fig. S7). The proteins respon-
sible for redox regulation of muscle adaptation and oxidant-
mediated muscle fatigue are unknown, but high levels of reac-
tive oxygen species (ROS) have been shown to result in con-
tractile dysfunction and muscle fatigue (42). Therefore, in fish
muscles, the normal function of the conserved cysteine residue in
β-PV may be that of a redox sensor, reacting with ROS to form
sulfenic or sulfinic acid (43). Although less reactive in Ellman’s
assay than the apo protein, there is slow reactivity (and thus
exposure to solvent) of the cysteine in Mg2+- and Ca2+-loaded
β-PV forms (SI Appendix, Fig. S4B).
Taken together, our findings demonstrate a protein system
(folded, globular) in which intermolecular disulfide-bond for-
mation primes amyloid formation. In amyloid formation of the
apo form of β-PV, disulfide-bridged (folded) dimers accelerate
the formation of primary nuclei, which can then be readily
elongated with monomers and dimers into amyloid fibrils in a
process lacking secondary processes. Although we studied a fish
protein, our findings have direct implications for possible sce-
narios in human neurodegenerative diseases in which oxidative
Fig. 6. Proposed dominant mechanism of fish apo β-PV amyloid fibril formation in the absence of reducing agents and in oxidizing conditions. Aggregation
is triggered by metal ion (e.g., Ca2+) release from the holo protein (MHOLO). The resulting apo monomers (MAPO) may associate to form dimers (DAPO), via
disulfide bond formation between exposed cysteines (through O2 mediated oxidation; DS-S). These dimers promote nuclei formation that then proceed to
amyloid fibrils via elongation by either monomeric (MAPO) or dimeric (DS-S, APO) apo β-PV additions. Here disulfide bridged dimers are shown as obligatory
intermediates because our data point toward this conclusion; however, we cannot exclude that amyloid fibrils may also form via pathways that do not include
disulfide-bridged dimers.
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stress is often a signature element (44). Under such conditions,
various oxidation reactions (e.g., disulfide, dityrosine, nitration)
may create covalent dimers of human amyloidogenic proteins
that in turn affect their aggregation potential.
Materials and Methods
Protein Expression and Purification. The G. morhua β-parvalbumin (A51874,
Gad m1) gene in a pET15b vector (with a His-tag) was transformed into BL21
(DE3) competent cells and grown in LB medium containing 100 mg/L car-
benicillin at 37 °C until an OD600 of ∼0.5. Protein expression was induced by
1 mM isopropyl β-D-1-thiogalactopyranoside and overnight incubation at
26 °C. The cells were centrifuged at 4,100 × g for 20 min, after which the
supernatant was decanted and the pellet resuspended in 10 mM Tris·HCl,
1 mM CaCl2, and protease inhibitor mixture (05892791001; Roche), pH 7.8.
The resuspended pellet was then sonicated on ice for 5 min (30 s on, 30 s off)
at 20% amplitude, followed by centrifugation at 15,000 × g for 30 min. The
supernatant was recovered, mixed 1:1 with 25 mM Tris·HCl, 1 mM CaCl2,
0.2 M NaCl, and 80 mM imidazole, and cleared by 30 min of centrifugation
at 15,000 × g.
The supernatant was then filtered (Nalgene rapid-flow filter, 0.2-μm aPES
membrane; Thermo Fisher Scientific) and loaded on an equilibrated (20 mM
Tris·HCl, 0.1 mM NaCl, and 40 mM imidazole) HisPrep FF 16/10 column (GE
Healthcare), followed by a gradient elution in an Äkta purifier 10 (GE
Healthcare) with increasing concentrations of 20 mM Tris·HCl, 0.1 M NaCl,
and 0.5 M imidazole. The protein was then collected and concentrated,
followed by loading onto a HiLoad 16/600 Superdex 75 pg (GE Healthcare)
equilibrated with 25 mM Tris·HCl and 1 mM CaCl2. The eluate was flash-
frozen in aliquots and stored at −80 °C. Just before the experiments, the
protein His-tag was cleaved with thrombin (35.5 NIH units/μM protein, 1 mM
β-PV) for 4 to 5 h at room temperature and 800 rpm shaking, and then
separated by an SEC column (Superdex 75 10/300; GE Healthcare) in 25 mM
Tris·HCl with 1 mM CaCl2 to create Ca
2+-loaded β-PV. For Mg2+-loaded β-PV
experiments, 0.1 M MgCl2 and 20 mM ethylene glycol-bis(β-aminoethyl
ether)-N,N,N′,N′ tetraacetic acid (EGTA) was added to the thrombin/PV so-
lution just before SEC, equilibrated in 25 mM Tris·HCl and 2 mM MgCl2.
To create apo β-PV, 5 mM EDTA was added just before the aggregation
experiments. The concentration of β-PV was determined by absorption using
an extinction coefficient of 1,950 cm−1 M−1 at 257 nm. Dimers were pre-
pared by incubating 100 μM β-PV in 25 mM Tris·HCl pH 8.2, 1 mM CaCl2,
5 mM EDTA, 7.7 mM NaN3, and 50 μM H2O2 for 20 h at 4 °C, followed by 0.2-
μm filtration and the addition of 0.1 M CaCl2 before injection into a
Superdex 75 10/300 column, equilibrated with 25 mM Tris·HCl and 1 mM
CaCl2. Preformed amyloid fiber seeds for experiments were prepared by
incubating 500 μM apo β-PV under the same conditions as for ThT aggre-
gation assays but in an Eppendorf tube without ThT for 20 h. The resulting
amyloid fibers were then used for experiments directly (full-length fibers), or
sonicated on ice for 10 s (5 s on, 10 s off) at 20% amplitude (to create shorter
fibrils and thus more amyloid fibril ends), followed by flash-freezing of ali-
quots in liquid nitrogen and storage at −80 °C when specified.
ThT Assay. Aggregation assays of SEC-purified β-PV was performed in qui-
escent conditions at 37 °C in 25 mM Tris·HCl pH 7.4, 150 mM NaCl, 1 mM
CaCl2 (or 2 mM MgCl2 when specified), 5 mM EDTA (for apo experiments),
7.7 mM NaN3, and 20 μM recrystallized ThT in 96-well plates, and fluores-
cence was measured with a plate reader (FLUOstar Optima or FLUOstar
Omega; BMG Labtech). Excitation was at 440 nm, and fluorescence was
recorded at 480 nm every 20 min.
Analysis of ThT Kinetic Curves. The half-times of PV amyloid fibril formation
were computed from ThT fluorescence kinetic data in the AmyloFit web
interface (7). The microscopic rate constants for PV amyloid formation were
determined using a global fitting strategy based on previously described
integrated rate laws for amyloid fibril growth (45). Theoretical curves de-
scribing the generation of amyloid aggregates were globally fitted to ex-
perimental ThT data to provide estimates of the involved rate constants
using the AmyloFit web interface. All fits were conducted using a 10-basin
hop algorithm with errors and using normalized ThT kinetics data, as de-
scribed previously (7).
Ellman’s Assay for Exposed Cysteines. Here 5,5′-dithiobis(2-nitrobenzoic acid)
(DTNB; Merck) was dissolved in 99.9% ethanol at a concentration of 8 mg/
mL. The reaction was performed at a concentration of 35 μM β-PV monomer
samples in 25 mM Tris·HCl pH 7.8 and 180 μM DTNB, with either 2 mM CaCl2
with or without 5 mM EDTA or 2 mM MgCl2 with 100 μM EGTA. The samples
were incubated at room temperature for 200 min and 412-nm absorption
was measured at timed intervals. The spectrophotometer (Lambda Bio+,
PerkinElmer) was blanked against the same working solution at each time
point but without the protein. Reacted thiols were calculated using the
extinction coefficient of 14,150 M−1 cm−1 at 412 nm.
Nonreducing SDS/PAGE. SDS/PAGE was performed with precast gels (NuPAGE
4 to 12% bis-Tris gel; Invitrogen) in MES buffer (NuPAGE MES SDS Running
Buffer; Invitrogen) at a constant 200 V for 40 min. Before β-PV fibrils were
run on SDS/PAGE, they were first partially sedimented by centrifugation at
100,000 × g for 2 h, followed by resuspension into 15 μL of 25 mM Tris·HCl
with 0.1 M CaCl2. In the case of fibrils exposed to DTT, the pellet was
resuspended with 25 mM Tris·HCl to remove trace DTT and then sedimented
again by centrifugation at 100,000 × g for 2 h before proceeding. The
resuspended pellet was then further diluted with 200 μL of
1,1,1,3,3,3-hexafluoro-2-propanol (Merck), followed by complete evapora-
tion of the liquid by N2 gas. Finally, 15 μL of Milli-Q water was used to sol-
ubilize the dried material, after which 4x LDS buffer (NuPAGE LDS Sample
Buffer 4x, Invitrogen) was added before running the gel. The gel was then
stained with a Coomassie solution and imaged with 715/30 far-red epi set-
tings (Chemidoc MP; Bio-Rad). Analysis of the gels was performed with Im-
age Lab Software 6.1 (Bio-Rad).
AFM. PV fibril samples were diluted with Milli-Q water (10–20 times) and
deposited on freshly cleaved mica. After 15 min, the mica was rinsed with
Milli-Q water and dried under a gentle nitrogen stream. AFM images were
recorded in intermittent contact mode in air using an NTEGRA Prima setup
(NT-MDT) and single crystal silicon cantilever (NSG01; TipsNano) with a force
constant of ∼5.1 N/m at a resonance frequency of ∼180 kHz. Images were
analyzed using Gwyddion software (46).
CD Spectroscopy. Far-UV CD spectra (190 to 260 nm) of PV monomers, di-
mers, and fibrils were collected at room temperature (21 ± 1 °C) using a
Chirascan CD spectropolarimeter (Applied Photophysics) and a quartz cu-
vette with a path length of 1 mm. Five scans were collected and averaged for
each sample at a time-per-point of 0.8 s, with a bandwidth of 1 nm and a
step size of 1 nm. The signal of the buffer was subtracted, and the resulting
intensities in millidegrees of the PV monomer and dimer samples were
converted to mean residue molar ellipticity (degrees M−1 m−1).
Data Availability.All study data are included in themain text and SI Appendix.
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